Joincare Pharmaceutical Group Industry Co Ltd (600380) — Cash Flow Quality Index
Joincare Pharmaceutical Group Industry Co Ltd (600380) has a Cash Flow Quality Index of 3.56x as of September 2025. Operating cash flow of CN¥1.09 Billion exceeds net income of CN¥306.27 Million, indicating high earnings quality where cash backs reported profits. Explore 600380 operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Joincare Pharmaceutical Group Industry Co Ltd Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Joincare Pharmaceutical Group Industry Co Ltd across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600380 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Joincare Pharmaceutical Group Industry Co Ltd (1999–2025)
Year-by-year earnings quality comparison for Joincare Pharmaceutical Group Industry Co Ltd. For live market cap and the full company financial profile, see 600380 company net worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.91x | CN¥3.89 Billion | CN¥1.34 Billion | ▲ +139.0% |
| 2024 | 1.22x | CN¥3.64 Billion | CN¥2.98 Billion | ▼ -55.2% |
| 2023 | 2.72x | CN¥3.93 Billion | CN¥1.44 Billion | ▲ +98.1% |
| 2022 | 1.37x | CN¥3.98 Billion | CN¥2.89 Billion | ▲ +40.1% |
| 2021 | 0.98x | CN¥2.56 Billion | CN¥2.61 Billion | ▼ -16.4% |
| 2020 | 1.17x | CN¥3.02 Billion | CN¥2.58 Billion | ▼ -6.1% |
| 2019 | 1.25x | CN¥2.31 Billion | CN¥1.85 Billion | ▼ -0.1% |
| 2018 | 1.25x | CN¥1.83 Billion | CN¥1.46 Billion | ▲ +212.5% |
| 2017 | 0.40x | CN¥1.87 Billion | CN¥4.67 Billion | ▼ -76.3% |
| 2016 | 1.69x | CN¥1.64 Billion | CN¥974.41 Million | ▲ +9.7% |
| 2015 | 1.54x | CN¥1.26 Billion | CN¥821.79 Million | ▲ +7.4% |
| 2014 | 1.43x | CN¥979.46 Million | CN¥683.80 Million | ▲ +28.8% |
| 2013 | 1.11x | CN¥635.52 Million | CN¥571.49 Million | ▼ -33.1% |
| 2012 | 1.66x | CN¥734.36 Million | CN¥441.81 Million | ▲ +25.5% |
| 2011 | 1.32x | CN¥650.36 Million | CN¥491.04 Million | ▲ +20.3% |
| 2010 | 1.10x | CN¥1.11 Billion | CN¥1.00 Billion | ▲ +42.7% |
| 2009 | 0.77x | CN¥605.66 Million | CN¥784.54 Million | ▼ -95.8% |
| 2008 | 18.21x | CN¥455.01 Million | CN¥24.99 Million | ▲ +4254.9% |
| 2007 | 0.42x | CN¥429.26 Million | CN¥1.03 Billion | ▼ -95.5% |
| 2006 | 9.19x | CN¥272.50 Million | CN¥29.64 Million | ▲ +435.3% |
| 2005 | 1.72x | CN¥363.13 Million | CN¥211.45 Million | ▲ +41.4% |
| 2004 | 1.21x | CN¥241.71 Million | CN¥199.06 Million | ▲ +31.2% |
| 2003 | 0.93x | CN¥172.25 Million | CN¥186.14 Million | ▼ -32.7% |
| 2002 | 1.38x | CN¥236.13 Million | CN¥171.63 Million | ▲ +23.3% |
| 2001 | 1.12x | CN¥223.79 Million | CN¥200.62 Million | ▲ +7.1% |
| 2000 | 1.04x | CN¥171.61 Million | CN¥164.79 Million | ▼ -45.8% |
| 1999 | 1.92x | CN¥109.82 Million | CN¥57.20 Million | — |